Home > Drug Search >
  • company_query: Autifony Therapeutics
  •   > 
Drug Filter
Category:
chemistry (19) biology (4)
Status:
NDA Filing (1) Phase Ⅱ (14) Phase Ⅰ (7) IND Filing (1)
Clinical Stage:
Pending (3) Active (18) Discontinued (2)
Indication:
Acute myeloid Leukemia (AML) (2) Alzheimer's disease (AD) (1) Atrial fibrillation (2) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (2) Chronic obstructive pulmonary disease (COPD) (1) Gastric cancer (2) Hepatocellular carcinoma (HCC) (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (3) Ovarian cancer (3) Respiratory tract infection (1) Rheumatoid arthritis (RA) (1) Schizophrenia (1) Solid tumours (4) Tinnitus (1) Urinary tract infections (1) Head and neck cancer (2) Colorectal cancer (1) Fallopian tube cancer (1) Systemic bacterial infections (1) Otorhinolaryngological infection (1) Malignant glioma (1) Renal carcinoma (1) Gram-negative bacterial infection (1) Hepatic fibrosis (1) Neuroendocrine tumors (NET) (1) Hearing loss (1) Gingival diseases (1) hematological malignancies (1) Inflammation (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top